A Simple Step Before Stimulator Surgery Cut Infections: Screening and Decolonizing for Staph

A Simple Step Before Stimulator Surgery Cut Infections: Screening and Decolonizing for Staph

By Ivan Urits, MD – Board Certified in Anesthesiology and Pain Medicine

Published Nov 17, 2026 | Category: Pain Medicine

Infection is one of the most common reasons a spinal cord stimulator or other implanted pain device has to be removed. Staphylococcus aureus ("staph") is the leading cause of surgical-site infections, and people who carry it on their skin or in their nose are at higher risk. A 2023 systematic review in Neuromodulation asked whether checking for staph before surgery, and clearing it when found, lowers infection after neuromodulation procedures.

This summary is based on the published abstract. Read the abstract on PubMed

What the authors did

The authors searched PubMed, the Cochrane Library and Embase through January 1, 2022, for studies that used staph swabbing and/or decolonization before neuromodulation procedures. They pooled the results in a meta-analysis.

  • Five observational cohort studies qualified, covering spinal cord stimulation, deep brain stimulation, intrathecal baclofen pumps and sacral neuromodulation.
  • Three studies used a nasal swab to decide who needed decolonization.
  • Decolonization usually combined nasal mupirocin ointment with a body wash, most often chlorhexidine soap.

What they found

A total of 1,914 patients were included: 860 without screening or decolonization and 1,054 with it.

  • Infections were much less common with the intervention: 0.95% (10 of 1,054) versus 6.86% (59 of 860).
  • Odds of infection fell by about 80% (odds ratio 0.19).
  • Four of the five studies found a significant difference on their own, and results were consistent across studies.

The authors conclude that preoperative staph swabbing and decolonization significantly decreased the odds of infection in neuromodulation procedures.

Why this matters

Removing an infected stimulator means another operation, weeks of antibiotics and the loss of a therapy that may have been working. A swab and a few days of ointment and body wash are inexpensive and low risk by comparison. Even though the evidence is observational, the size and consistency of the drop in infections make this an easy step for implant teams to adopt and measure.

Limitations

All five studies were observational, not randomized, so other changes in care over time may have contributed. The number of studies was small, and they mixed several types of implanted devices. More research is needed to confirm the size of the benefit for spinal cord stimulators specifically.

Safety takeaways: how to apply it

For pain physicians and procedure teams

  • Build staph screening and decolonization into the pre-implant checklist for spinal cord stimulators and intrathecal pumps.
  • Use a defined regimen, such as nasal mupirocin plus a chlorhexidine body wash, and confirm the patient completed it before surgery.
  • Combine it with the other infection-control steps you already use, such as skin prep, timely antibiotic prophylaxis and wound care instructions.

For hospitals, clinics and safety leaders

  • Track device infections and explants so you can see whether a decolonization protocol is working.

For patients and families

  • Ask whether you will be screened for staph before your implant and how to use any nasal ointment or body wash you are given.
  • Report redness, drainage, fever or worsening pain at the incision right away.

Reference

  1. Patel N, Gold J, Brown NJ, Abraham M, Beyer RS, Yang C, et al. Staphylococcus aureus swabbing and decolonization before neuromodulation procedures: a systematic review and meta-analysis. Neuromodulation. 2023 Jul;26(5):928-937. doi:10.1016/j.neurom.2022.07.013. PMID: 36198512. PubMed: https://pubmed.ncbi.nlm.nih.gov/36198512/

This article is educational information, not legal or medical advice.

Next
Next

Smaller Opioid Prescriptions After Surgery, Without More Refills